Neuromics offers antibodies and cell based assays that can help researchers find answers to questions about the COVID-19 virus. We offer SARS-CoV2 S-Protein ACE2 Binding Domain antibodies, which target the binding domain of the ACE2 protein where SARS-CoV2 has been shown to attach. Additionally, recent research has shown that COVID-19 can pass through the blood-brain barrier. Our 3-D Human Blood-Brain Barrier Model is the perfect tool to explore this phenomenon.

Many of our reagents have already been used by customers in COVID-19 related publications. See them here. 

Product Highlights: